Cargando…
Structure of the active pharmaceutical ingredient bismuth subsalicylate
Structure determination of pharmaceutical compounds is invaluable for drug development but remains challenging for those that form as small crystals with defects. Bismuth subsalicylate, among the most commercially significant bismuth compounds, is an active ingredient in over-the-counter medications...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008038/ https://www.ncbi.nlm.nih.gov/pubmed/35418171 http://dx.doi.org/10.1038/s41467-022-29566-0 |
_version_ | 1784686964217217024 |
---|---|
author | Svensson Grape, Erik Rooth, Victoria Nero, Mathias Willhammar, Tom Inge, A. Ken |
author_facet | Svensson Grape, Erik Rooth, Victoria Nero, Mathias Willhammar, Tom Inge, A. Ken |
author_sort | Svensson Grape, Erik |
collection | PubMed |
description | Structure determination of pharmaceutical compounds is invaluable for drug development but remains challenging for those that form as small crystals with defects. Bismuth subsalicylate, among the most commercially significant bismuth compounds, is an active ingredient in over-the-counter medications such as Pepto-Bismol, used to treat dyspepsia and H. pylori infections. Despite its century-long history, the structure of bismuth subsalicylate is still under debate. Here we show that advanced electron microscopy techniques, namely three-dimensional electron diffraction and scanning transmission electron microscopy, can give insight into the structure of active pharmaceutical ingredients that are difficult to characterize using conventional methods due to their small size or intricate structural features. Hierarchical clustering analysis of three-dimensional electron diffraction data from ordered crystals of bismuth subsalicylate revealed a layered structure. A detailed investigation using high-resolution scanning transmission electron microscopy showed variations in the stacking of layers, the presence of which has likely hindered structure solution by other means. Together, these modern electron crystallography techniques provide a toolbox for structure determination of active pharmaceutical ingredients and drug discovery, demonstrated by this study of bismuth subsalicylate. |
format | Online Article Text |
id | pubmed-9008038 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-90080382022-04-28 Structure of the active pharmaceutical ingredient bismuth subsalicylate Svensson Grape, Erik Rooth, Victoria Nero, Mathias Willhammar, Tom Inge, A. Ken Nat Commun Article Structure determination of pharmaceutical compounds is invaluable for drug development but remains challenging for those that form as small crystals with defects. Bismuth subsalicylate, among the most commercially significant bismuth compounds, is an active ingredient in over-the-counter medications such as Pepto-Bismol, used to treat dyspepsia and H. pylori infections. Despite its century-long history, the structure of bismuth subsalicylate is still under debate. Here we show that advanced electron microscopy techniques, namely three-dimensional electron diffraction and scanning transmission electron microscopy, can give insight into the structure of active pharmaceutical ingredients that are difficult to characterize using conventional methods due to their small size or intricate structural features. Hierarchical clustering analysis of three-dimensional electron diffraction data from ordered crystals of bismuth subsalicylate revealed a layered structure. A detailed investigation using high-resolution scanning transmission electron microscopy showed variations in the stacking of layers, the presence of which has likely hindered structure solution by other means. Together, these modern electron crystallography techniques provide a toolbox for structure determination of active pharmaceutical ingredients and drug discovery, demonstrated by this study of bismuth subsalicylate. Nature Publishing Group UK 2022-04-13 /pmc/articles/PMC9008038/ /pubmed/35418171 http://dx.doi.org/10.1038/s41467-022-29566-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Svensson Grape, Erik Rooth, Victoria Nero, Mathias Willhammar, Tom Inge, A. Ken Structure of the active pharmaceutical ingredient bismuth subsalicylate |
title | Structure of the active pharmaceutical ingredient bismuth subsalicylate |
title_full | Structure of the active pharmaceutical ingredient bismuth subsalicylate |
title_fullStr | Structure of the active pharmaceutical ingredient bismuth subsalicylate |
title_full_unstemmed | Structure of the active pharmaceutical ingredient bismuth subsalicylate |
title_short | Structure of the active pharmaceutical ingredient bismuth subsalicylate |
title_sort | structure of the active pharmaceutical ingredient bismuth subsalicylate |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008038/ https://www.ncbi.nlm.nih.gov/pubmed/35418171 http://dx.doi.org/10.1038/s41467-022-29566-0 |
work_keys_str_mv | AT svenssongrapeerik structureoftheactivepharmaceuticalingredientbismuthsubsalicylate AT roothvictoria structureoftheactivepharmaceuticalingredientbismuthsubsalicylate AT neromathias structureoftheactivepharmaceuticalingredientbismuthsubsalicylate AT willhammartom structureoftheactivepharmaceuticalingredientbismuthsubsalicylate AT ingeaken structureoftheactivepharmaceuticalingredientbismuthsubsalicylate |